NEWS: NOVEMBER 2004

-12/10/2004-

Press Release: Guava Technologies, a leading supplier of integrated cellular analysis systems for life science research, has announced the availability of a new bibliography providing scientists with easy access to published articles in the field of cell screening. To read press release click here.

Kosan Biosciences Inc. and Roche initiate Phase I clinical trials of KOS-1584 (9,10-didehydroepothilone D) for the treatment of advanced malignancies. To read article click here.

FDA adds heat warning to Pfizer Inc.'s painkiller Bextra. To read article click here.

ViroLogic Inc. and ACLARA BioSciences Inc. to merge. To read article click here.

FDA grants orphan drug status to PTC Therapeutics Inc.'s PTC124 for the treatment of cystic fibrosis. To read article click here.

Phenomix Corporation and Plexxikon Inc.'s research collaboration produces compound PLX647, a dual c-Kit and FMS kinase inhibitor for inflammation. To read article click here.

Myriad Genetics Inc. files IND application with the FDA for pro-apoptotic anticancer agent MPC-6827. To read article click here.

Panacos Pharmaceuticals Inc. initiates Phase 2a clinical trials of PA-457 for HIV. To read article click here.

-12/09/2004-

Press Release: Radleys have introduced an innovative new V4 zero dead space stopcock for its range of jacketed glass reaction systems. To read press release click here.

Press Release: The latest edition of genUpdate - a newsletter covering the latest advances in applications-driven consumables and reagents for Genomic, Proteomic and Cell Biology research is available as a downloadable pdf file from the Genetix website. To read press release click here.

Johnson & Johnson's compound R207910 show promising results in Phase I clinical trials for tuberculosis. To read article click here.

Genencor International Inc. to develop and commercialize two cancer candidates from the National Cancer Institute (NCI). To read article click here.

Immtech International Inc. receives U.S. patent 6, 815,461 entitled "Method For Inhibiting Retroviral Integrase." To read article click here.

-12/08/2004-

Press Release: Available from Tecan the GENios Pro reader combines an advanced on-board injector system and up to six detection modes in a very compact, high-performance platform. To read press release click here.

Press Release: Genevac, world leader in solvent removal for drug discovery applications, has announced its presence at Pittcon 2005 due to be held in Orlando, USA (27th February - 3rd March 2005). To read press release click here.

Invitrogen Corp. to acquire Shanghai-based Bio Asia. To read article click here.

-12/07/2004-

Array BioPharma Inc. expands intellectual property rights granted to InterMune Inc. on compounds discovered in their hepatitis C (HCV) drug discovery collaboration. To read article click here.

Amgen to buy back $5 billion shares. To read article click here.

FDA approves Savient Pharmaceuticals Inc.'s Nuflexxa for arthritis pain treatment. To read article click here.

Cell Genesys Inc.'s GVAX vaccine showen to reduce cancer growth. To read article click here.

ArQule Inc. initiates Phase 1b clinical trials of ARQ 501 and Taxotere. To read article click here.

Serono and Micromet form anticancer drug collaboration. To read article click here.

-12/06/2004-

Press Release: Genetix have announced a new 384-well High Sample Recovery plate adding to their range of high quality plastic microplates for use in bioresearch applications. To read press release click here.

FDA grants "fast-track" designation to Amgen's AMG 531 and AMG 706 for an autoimmune bleeding disorder and cancer treatment, respectively. To read article click here.

Corgentech Inc.'s Edifoligide fails clinical trials for the treatment of vein graft failure of the heart and leg. To read article click here.

-12/03/2004-

Maxygen Inc. to advance novel factor VII program into preclinical development. To read article click here.

Celgene Corp. and Pharmion Corp. extend collaboration for worldwide development of Thalomid® (Thalidomide). To read article click here.

-12/02/2004-

FDA grants "fast-track" designation to CuraGen Corp.'s CG53135 protein for treatment of chemotherapy-related mouth sores. To read article click here.

Guilford Pharmaceuticals Inc. to acquire ProQuest Pharmaceuticals Inc. To read article click here.

Genaissance Pharmaceuticals Inc. and Sygen International plc form research collaboration. To read article click here.

-12/01/2004-

PhotoMedex Inc. to acquire ProCyte Corporation. To read article click here.

Xencor and Genentech Inc. to work together on next-generation therapeutic antibodies for cancer and autoimmune diseases. To read article click here.

Arena Pharmaceuticals Inc. initiates Phase I clinical trials of APD125 for the treatment of insomnia. To read article click here.

Sanofi-Synthelabo Recherche and Tripos Inc. form partnership. To read article click here.